Purification, Characterization, and Mode of Action of Pentocin JL-1, a Novel Bacteriocin Isolated from<i> Lactobacillus pentosus</i>, against Drug-Resistant<i> Staphylococcus aureus</i>

<div>Analysis of ΔΨ of MRSA GIM1.771 cells. MRSA GIM 1.771 cells were treated with 3x MIC (a), 2x MIC (b), and 1x MIC (c) pentocin JL-1, respectively. 1% Triton X-100 was added as ΔΨ 100% dissipation and 0.05% (<i>w/v</i>) acetic acid was used as the negative control.</div>

BioMed Research International

fig5

Figure 5

Figure 5: Purification, Characterization, and Mode of Action of Pentocin JL-1, a Novel Bacteriocin Isolated from<i> Lactobacillus pentosus</i>, against Drug-Resistant<i> Staphylococcus aureus</i> 

Figure 5 | Purification, Characterization, and Mode of Action of Pentocin JL-1, a Novel Bacteriocin Isolated from Lactobacillus pentosus, against Drug-Resistant Staphylococcus aureus 